{
  "main_header": {
    "sid": 365157,
    "name": "Bandaram Pharma",
    "stock_name": "Bandaram Pharma",
    "full_name": "Bandaram Pharma Packtech Ltd",
    "name_url": "stocks-analysis/bandaram-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.61",
    "chg": -0.92,
    "chgp": "-3.47%",
    "dir": -1,
    "prev_price": "26.53",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524602,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE875N01036",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "2.57 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bandaram-pharma-365157-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bandaram Pharma Packtech: Analytical Review Highlights Key Shifts in Market Assessment",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bandaram-pharma-packtech-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3759637",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_mojoScore_3759637.png",
        "date": "2025-12-16 08:26:12",
        "description": "Bandaram Pharma Packtech, a player in the Healthcare Services sector, has experienced notable shifts in its market evaluation, reflecting changes across quality, valuation, financial trends, and technical indicators. This article examines the underlying factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Why is Bandaram Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bandaram-pharma-fallingrising-3757769",
        "imagepath": "",
        "date": "2025-12-13 01:08:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Volatility and Price Movement</strong></p>\n<p>Despite opening the day with a positive gap of 4.89%, the stock failed to sustain its early gains. It reached an intraday high of ₹32.84, mirroring the initial optimism among investors. However, the momentum reversed sharply, and the share price slid to an intraday low of ₹29.75, ultimately closing near this bottom. This wide trading range of ₹3.09 within a single session highlights the heightened uncertainty and selling pressure that prevailed throughout the day.</p>\n<p><strong>Volume and Investor Participation</strong></p>\n<p>Investor engagement surged notably, with delivery volumes on 11 Dec soaring to 18,910 shares, a staggering increase of 1589.42% compared to the five-day average. This spike in delivery volume indicates a significa..."
      },
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3748086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3748086.png",
        "date": "2025-12-05 09:40:14",
        "description": "Bandaram Pharma Packtech Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.98% today and exhibiting no buying interest. This persistent downtrend, marked by four consecutive days of losses, signals distress selling within the healthcare services sector."
      },
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3745827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3745827.png",
        "date": "2025-12-04 09:35:13",
        "description": "Bandaram Pharma Packtech Ltd experienced a pronounced decline on 4 Dec 2025, marked by exclusive selling activity and a lower circuit scenario. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and a lack of buyer interest."
      },
      {
        "title": "How has been the historical performance of Bandaram Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bandaram-pharma-3744729",
        "imagepath": "",
        "date": "2025-12-03 22:49:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Bandaram Pharma’s consolidated net sales have nearly doubled from ₹18.73 crores in March 2023 to ₹36.96 crores in March 2025, reflecting a compound growth trend. This increase in sales was accompanied by a proportional rise in raw material costs, which grew from ₹16.05 crores to ₹30.96 crores over the same period. The company’s total operating income mirrored this growth, with no other operating income reported during these years.</p>\n<p>Operating profit before depreciation, interest, and tax (PBDIT) excluding other income remained stable at ₹2.82 crores in both March 2024 and March 2025, up from ₹1.16 crores in March 2023. Including other income, operating profit edged slightly higher to ₹2.91 crores in March 2025. Despite the rise in sales, the ope..."
      },
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3743302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3743302.png",
        "date": "2025-12-03 09:40:12",
        "description": "Bandaram Pharma Packtech Ltd has encountered significant selling pressure on 3 December 2025, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company’s shares opened sharply lower and have since traded at the day’s low, signalling distress selling and a challenging market environment."
      },
      {
        "title": "Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Sharp Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3740941",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_sellers_3740941.png",
        "date": "2025-12-02 09:35:13",
        "description": "Bandaram Pharma Packtech Ltd experienced a significant downturn on 2 December 2025, with the stock plunging by 10.0% in a single trading session. The day was marked by extreme selling pressure, with no buyers recorded, signalling distress selling and a notable shift in market sentiment for the healthcare services company."
      },
      {
        "title": "Bandaram Pharma Packtech Surges with Unprecedented Buying Interest and Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bandaram-pharma-packtech-hits-upper-circuit-amid-unprecedented-buying-frenzy-3737759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BandaramPharmaP_only_buyers_3737759.png",
        "date": "2025-12-01 09:40:09",
        "description": "Bandaram Pharma Packtech Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and a lack of sellers, signalling a potential multi-day circuit scenario for the healthcare services stock."
      },
      {
        "title": "Is Bandaram Pharma overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bandaram-pharma-overvalued-or-undervalued-3736396",
        "imagepath": "",
        "date": "2025-11-29 08:14:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Bandaram Pharma’s Valuation Metrics</strong></p>\n<p>At a price of ₹39.60, Bandaram Pharma trades with a price-to-earnings (PE) ratio of 216.0, which is exceptionally high compared to typical industry standards. This elevated PE ratio suggests that investors are pricing in significant future growth or are willing to pay a premium for the company’s prospects. However, the company’s return on capital employed (ROCE) and return on equity (ROE) stand at a modest 3.88% and 1.72% respectively, indicating limited profitability relative to the capital invested.</p>\n<p>The price-to-book (P/B) ratio of 3.71 further highlights that the stock is valued well above its net asset value, while the enterprise value to EBITDA (EV/EBITDA) multiple of 30.28 also points to a premium valuation. The P..."
      }
    ],
    "total": 130,
    "sid": "365157",
    "stock_news_url": "https://www.marketsmojo.com/news/bandaram-pharma-packtech-365157"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Bandaram Pharma Packtech Ltd",
      "datetime": "02-Dec-2025",
      "details": "The Exchange has sought clarification from Bandaram Pharma Packtech Ltd on December 2 2025 with reference to Movement in Price.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Price Movement",
      "datetime": "02-Dec-2025",
      "details": "Clarification on Price Movement",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 13.11.2025",
      "datetime": "13-Nov-2025",
      "details": "Outcome of Board meeting held on 13.11.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has declared <strong>1%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Bandaram Pharma Packtech Ltd has announced <strong>3:1</strong> rights issue, ex-date: 30 Jun 23",
          "dt": "2023-06-30",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Bandaram Pharma Packtech: Analytical Review Highlights Key Shifts in Market Assessment

2025-12-16 08:26:12

Bandaram Pharma Packtech, a player in the Healthcare Services sector, has experienced notable shifts in its market evaluation, reflecting changes across quality, valuation, financial trends, and technical indicators. This article examines the underlying factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive understanding of its current standing.

Read More

Why is Bandaram Pharma falling/rising?

2025-12-13 01:08:15

Intraday Volatility and Price Movement

Despite opening the day with a positive gap of 4.89%, the stock failed to sustain its early gains. It reached an intraday high of ₹32.84, mirroring the initial optimism among investors. However, the momentum reversed sharply, and the share price slid to an intraday low of ₹29.75, ultimately closing near this bottom. This wide trading range of ₹3.09 within a single session highlights the heightened uncertainty and selling pressure that prevailed throughout the day.

Volume and Investor Participation

Investor engagement surged notably, with delivery volumes on 11 Dec soaring to 18,910 shares, a staggering increase of 1589.42% compared to the five-day average. This spike in delivery volume indicates a significa...

Read More

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-05 09:40:14

Bandaram Pharma Packtech Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.98% today and exhibiting no buying interest. This persistent downtrend, marked by four consecutive days of losses, signals distress selling within the healthcare services sector.

Read More

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-04 09:35:13

Bandaram Pharma Packtech Ltd experienced a pronounced decline on 4 Dec 2025, marked by exclusive selling activity and a lower circuit scenario. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and a lack of buyer interest.

Read More

How has been the historical performance of Bandaram Pharma?

2025-12-03 22:49:28

Revenue and Profit Growth

Bandaram Pharma’s consolidated net sales have nearly doubled from ₹18.73 crores in March 2023 to ₹36.96 crores in March 2025, reflecting a compound growth trend. This increase in sales was accompanied by a proportional rise in raw material costs, which grew from ₹16.05 crores to ₹30.96 crores over the same period. The company’s total operating income mirrored this growth, with no other operating income reported during these years.

Operating profit before depreciation, interest, and tax (PBDIT) excluding other income remained stable at ₹2.82 crores in both March 2024 and March 2025, up from ₹1.16 crores in March 2023. Including other income, operating profit edged slightly higher to ₹2.91 crores in March 2025. Despite the rise in sales, the ope...

Read More

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Consecutive Losses

2025-12-03 09:40:12

Bandaram Pharma Packtech Ltd has encountered significant selling pressure on 3 December 2025, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company’s shares opened sharply lower and have since traded at the day’s low, signalling distress selling and a challenging market environment.

Read More

Bandaram Pharma Packtech Faces Intense Selling Pressure Amid Sharp Decline

2025-12-02 09:35:13

Bandaram Pharma Packtech Ltd experienced a significant downturn on 2 December 2025, with the stock plunging by 10.0% in a single trading session. The day was marked by extreme selling pressure, with no buyers recorded, signalling distress selling and a notable shift in market sentiment for the healthcare services company.

Read More

Bandaram Pharma Packtech Surges with Unprecedented Buying Interest and Upper Circuit Lock

2025-12-01 09:40:09

Bandaram Pharma Packtech Ltd has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand and a lack of sellers, signalling a potential multi-day circuit scenario for the healthcare services stock.

Read More

Is Bandaram Pharma overvalued or undervalued?

2025-11-29 08:14:43

Understanding Bandaram Pharma’s Valuation Metrics

At a price of ₹39.60, Bandaram Pharma trades with a price-to-earnings (PE) ratio of 216.0, which is exceptionally high compared to typical industry standards. This elevated PE ratio suggests that investors are pricing in significant future growth or are willing to pay a premium for the company’s prospects. However, the company’s return on capital employed (ROCE) and return on equity (ROE) stand at a modest 3.88% and 1.72% respectively, indicating limited profitability relative to the capital invested.

The price-to-book (P/B) ratio of 3.71 further highlights that the stock is valued well above its net asset value, while the enterprise value to EBITDA (EV/EBITDA) multiple of 30.28 also points to a premium valuation. The P...

Read More

View All News